The Union Ministry of Health is mulling shutting down digital pharmacies due to some concerns like misuse of data, Antimicrobial Resistance (AMR) and predatory pricing of medicines. In the latest development in this regard, FICCI has written a letter to the Drugs Controller General of Ind
Dr PBN Prasad will hold the charge of the post of Drug Controller of India from February 16 to 28 this year or until further orders, an official notice said on Wednesday.
The Union Public Service Commission (UPSC) has recommended the name of Dr Rajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).
According to MSD, Keytruda is the first cancer immunotherapy to be approved in India for the treatment of cervical cancer and the first immunotherapy to be approved as a first-line treatment for a significant sub-group of patients, who otherwise only had the option of chemotherapy as their t
The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.
Streptococcus pneumonia infection remains one of the leading causes of death among children under five in India and developing countries. BE's PCV14 Vaccine will help prevent invasive pneumococcal infection and save millions of lives worldwide. PCV14 may be administered to infants of 6, 1
The Drugs Controller General of India (DCGI) has given approval to intranasal "Five Arms" booster dose for restricted use for COVID-19 patients, it is learnt.
The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months for the second time, according to an order issued by the Union Health Ministry.
DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in September this year applied for DCGI's approval for market authorization of its "Five Arms" intranasal heterologous booster dose, and it has now announced that iNCOVACC (BBV154) has re
New Delhi [India], October 21 (ANI): Chief Scientist at World Health Organisation (WHO) Dr Soumya Swaminathan has said that it's very important for India to have a strong regulatory system to remain a leader in the generic medicine and vaccines space.
New Delhi [India], October 15 (ANI): Drugs Controller General of India (DCGI) on Saturday replied to World Health Organisation (WHO) and said as per the recently formed technical committee, the clinical features and the treatment received by the children as shared by WHO so far are inadeq